Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MedRing intravaginal insulin aspart pharmacokinetic crossover study in women with type 1 diabetes
NL-OMON51108Active, not recruiting
- Sponsor
- LiGalli
- Start
- Sep 2021
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of human insulin in diabetes mellitus type 1 (T1D) (2 arms), sponsored by LiGalli. Primary endpoints: AUCinf, AUClast and 9 more. Started Sep 2021; status: active, not recruiting.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON51108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON51108.